Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

9 Jul 2009 07:00

RNS Number : 3701V
Charlemagne Capital Limited
09 July 2009
 



9 July 2009

Charlemagne Capital Announces Unaudited Revenues and Assets under Management for the Six Months Ended 30 June 2009

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 23 September 2009.

Key highlights and Group AuM

Good recovery in emerging markets in the first half of the year

Group AuM total up 28.2% since 31 March 2009 to US$2.4 billion as at 30 June 2009.

Group AuM total up 9.0% since 1 January 2009. 

Excellent long-term fundamentals for these markets

The table below sets out the Group's AuM as at 30 June 2009 and the movements experienced in each product range in the period since 1 January 2009. 

1 January 2009

Net Subscriptions

Reorganisation

Net Performance

30 June 2009

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

392

(81)

(20.7)

-

-

107

30.4

418

6.6

OCCO

247

(180)

(72.9)

(20)

(8.1)

32

21.8

79

(68.0)

Institutional Advisory

534

(53)

(9.9)

-

-

174

34.3

655

22.7

Institutional Mandates

751

(10)

(1.3)

20

2.7

241

31.9

1,002

33.4

Specialist

255

(20)

(7.8)

-

-

(13)

(5.3)

222

(12.9)

Total

2,179

(344)

(15.8)

-

-

541

27.0

2,376

9.0

Notes

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

Unaudited revenue numbers for the six months ended 30 June 2009 

Net management fees receivable were US$8.2 million compared with US$25.1 million for the first six months of 2008, reflecting the lower average AuM in the first half of 2009. 

Crystallised performance fees were US$0.3 million compared with US$3.3 million for the comparative period in 2008. Accruing performance fees which have not crystallised were US$0.9 million compared with US$1.2 million as at the same date in 2008. 

 

Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the Group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility. 

Dividend policy 

In the absence of unforeseen circumstances, the Group intends to declare an ordinary interim dividend in respect of the six months to 30 June 2009. Further details will be provided in the interim results announcement. 

Summary

Emerging markets have made a good recovery in the first half of this year, following the very sharp falls of the second half of 2008. This is partly a reaction to the savage falls that preceded the rally but also, in our view, a result of a growing recognition that emerging economies are poised to become a much more significant force in the world from now on. While developed economies are likely to see structurally lower growth, due to their heavy debt burdens, emerging markets are generally much less indebted. Our discussions with investors and their advisors indicate that strategic asset allocation will increasingly focus on emerging markets. Hence, the strong long-term fundamentals remain intact and Charlemagne is well positioned to benefit from the opportunities presented in the asset class. 

Enquiries:

Charlemagne Capital

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

David McMahon, Finance Director

Tel. 01624 640200

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

Gemma Froggatt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDRRSGGGCI
Date   Source Headline
15th Mar 20167:01 amRNSDividend Declaration
15th Mar 20167:00 amRNSFinal Results
17th Feb 20163:07 pmRNSTR1 - Notification of Major Interest in Shares
19th Jan 20167:00 amRNSTrading Statement
27th Nov 201511:28 amRNSForm 8.3 - Al Noor Hospitals Group PLC
26th Nov 201510:42 amRNSForm 8.3 - Al Noor Hospitals Group PLC
25th Nov 201510:48 amRNSForm 8.3 - Al Noor Hospitals Group PLC
23rd Nov 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
19th Nov 201510:56 amRNSForm 8.3 -NMC Health PLC
18th Nov 201511:29 amRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 201510:25 amRNSForm 8.3 - NMC Health PLC
17th Nov 20159:42 amRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 20159:35 amRNSForm 8.3 - NMC Health Plc
9th Nov 201511:38 amRNSForm 8.3 - Al Noor Hospitals
4th Nov 20154:32 pmRNSForm 8.3 - NMC Health Plc
28th Oct 201511:34 amRNSForm 8.3 - Al Noor Hospitals
28th Oct 201511:30 amRNSForm 8.3 - NMC Health PLC
16th Oct 201511:27 amRNSHolding(s) in Company
9th Oct 20157:00 amRNSQ3 2015 AUM Update
22nd Sep 20157:01 amRNSDividend Declaration
22nd Sep 20157:00 amRNSHalf Yearly Report
15th Jul 20157:00 amRNSInterim Management Statement
19th Jun 20156:00 pmRNSHolding(s) in Company
19th Jun 201512:17 pmRNSResult of AGM
15th May 20153:05 pmRNSAnnual Report and Notice of AGM
29th Apr 20156:06 pmRNSHolding(s) in Company
10th Apr 20157:00 amRNSQ1 2015 AUM Update
30th Mar 20159:00 amRNSQuadruple Lipper Award Win for Charlemagne Capital
17th Mar 20157:05 amRNSDividend Declaration
17th Mar 20157:00 amRNSFinal Results
13th Jan 20157:00 amRNSTrading Statement
23rd Dec 20144:28 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSQ3 2014 AUM Update
18th Sep 201410:38 amRNSDirector/PDMR Shareholding
17th Sep 201411:46 amRNSDirector/PDMR Shareholding
16th Sep 20147:30 amRNSDividend Declaration
16th Sep 20147:00 amRNSHalf Yearly Report
15th Jul 20147:00 amRNSInterim Management Statement
20th Jun 20144:02 pmRNSResult of AGM
19th May 20149:20 amRNSMAGNA MENA FUND REACHES 3 YEAR ANNIVERSARY
14th May 20142:38 pmRNSNotice of AGM
14th May 20147:00 amRNSDirector/PDMR Shareholding
9th May 20148:16 amRNSTriple Lipper Award Win for Charlemagne Capital
28th Apr 20143:27 pmRNSChange to Significant Shareholding
25th Apr 201412:49 pmRNSHolding(s) in Company
25th Apr 201410:30 amRNSHolding(s) in Company
8th Apr 20147:00 amRNSQ1 2014 AUM Update
18th Mar 20147:05 amRNSDividend Declaration
18th Mar 20147:00 amRNSFinal Results
14th Jan 20144:12 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.